Management of people with early or very early stage hepatocellular carcinoma: a network meta-analysis (Q24186856)

inferred from title

author

Kurinchi Selvan Gurusamy

1

0 references

Emmanuel Tsochatzis

2

0 references

Brian R Davidson

4

object named as

Brian R Davidson

0 references

Douglas Thorburn

3

object named as

Douglas Thorburn

0 references

author name string

Brian R Davidson

Cochrane Database of Systematic Reviews

4

0 references

language of work or name

English

0 references

publication date

1 September 1996

0 references

published in

0 references

cites work

Recurrence patterns and prognostic factors in patients with hepatocellular carcinoma in noncirrhotic liver: a multi-institutional analysis

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Hepatocellular carcinoma epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Prospective validation of the Barcelona Clinic Liver Cancer staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Efficacy of new generation antidepressants: differences seem illusory

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Checking consistency in mixed treatment comparison meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Hepatocellular carcinoma in the noncirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Methods of preventing bacterial sepsis and wound complications after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Thermal ablation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: recent trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Screening for hepatocellular carcinoma in chronic liver disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Combination of direct and indirect evidence in mixed treatment comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Industry sponsorship and research outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

A comparison of methods to detect publication bias in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Oral contraception and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Radiofrequency ablation of liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

How to use an article reporting a multiple treatment comparison meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Intention-to-treat analysis: implications for quantitative and qualitative research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

World review of laparoscopic liver resection-2,804 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Comparison of staging systems to predict survival in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

TACE versus TAE as therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Hepatocellular carcinoma incidence trends in Canada: analysis by birth cohort and period of diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

21 January 2018

Hepatic tumor ablation

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Sample size and power considerations in network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Family history of liver cancer and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Staging classifications for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Molecular classification of hepatocellular carcinoma anno 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

7 January 2021

inferred from DOI database lookup

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

7 January 2021

inferred from DOI database lookup

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study

1 reference

https://api.crossref.org/works/10.1002/14651858.CD011650

7 January 2021